Does protein kinase C play a pivotal role in the mechanisms of ischemic preconditioning?

Cardiovascular Drugs and Therapy

Volumn 10, Issue 6, 1997, Pages 775-786

  Gho, Ben C G ^a   Eskildsen Helmond, Yvonne E G ^b   De Zeeuw, Sandra ^a   Lamers, Jos M J ^b   Verdouw, Pieter D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Infarct size; Ischemic preconditioning; Myocardial ischemia; Myocardial protection; Phospholipase C; Phospholipase D; Protein kinase C

Indexed keywords

PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C;

HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENZYME ACTIVATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOENZYMES; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C;

EID: 0030965609     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00053036     Document Type: Review

References (83)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;75:1124-1136.
2. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542-550.
3. Zager RA, Baltes LA, Sharma HM, Jurkowitz MS. Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 1984;26:689-700.
4. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, Calvo MA, Suzuki S. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993;25: 3303-3304.
5. Mounsey RA, Pang CY, Forrest C. Preconditioning: a new technique for improved muscle flap survival. Otolaryngology-Head and Neck Surg 1992;107:549-552.
6. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990;528:21-24.
7. Gho BC, Schoemaker RG, Van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in non-cardiac tissue. Circulation 1996;94:2193-2200.
8. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72:1293-1299.
9. Marber MS, Latchman DS, Walker M, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-1272.
10. Baxter GF, Goma FM, Yellon DM. Duration of the "second window of protection" following ischaemic preconditioning in the rabbit. J Mol Cell Cardiol 1995;27:A162 (Abstract).
11. Thornton J, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85: 659-665.
12. Toombs CF, McGee DS, Johnston WE, Vinten-Johanson J. Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992;86:986-994.
13. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
14. Rohmann S, Weygandt H, Schelling P, Soei LK, Verdouw PD, Lues I. Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res Cardiol 1994; 89:563-576.
15. Downey JM, Cohen MV, Ytrehus K, Liu Y. Cellular mechanisms in ischemic preconditioning: The role of adenosine and protein kinase C. Ann NY Acad Sci 1994;723:882-898.
16. Wall TM, Sheeny R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994; 270:681-689.
17. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit heart. Circ Res 1995;77:611-621.
18. Hu K, Nattel S. Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92(8):2259-2265.
19. Strasser RH, Marquetant R. Sensitization of the beta-adrenergic system in acute myocardial ischaemia by a protein kinase C-dependent mechanism. Eur Heart J 1991;12 Suppl F:48-53.
20. Yao Z, Gross GJ. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol. 264 (Heart Circ Physiol 33) 1993;H2221-H2225.
21. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res 1993;73:1193-1201.
22. Wang P, Gallagher KP, Downey JP, Cohen MV. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 1996;28:579-588.
23. Schultz JEJ, Hsu A, Gross GJ. Morphine-induced cardioprotection is mediated via the ATP-sensitive potassium channel in the rat heart (Abstract). FASEB J 1996;10:A12, 68.
24. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovase Res 1995; 30:478-492.
25. De Jonge HW, Van Heugten HAA, Lamers JMJ. Signal transduction by the phosphatidylinositol cycle in myocardium. J Mol Cell Cardiol 1995;27:93-106.
26. Cohen MV, Downey JM. Preconditioning during ischemia: basic mechanism and potential clinical applications. Cardiol Rev 1995;3:137-149.
27. Hu K, Duan D, Nattel S. Protein kinase C-mediated activation of ATP-sensitive potassium current-The missing link in ischemic preconditioning. Circulation 1995;92:2259-2265.
28. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996;93:781-791.
29. Donnely TJ, Sievers RE, Visseren FLJ, Welch WJ, Wolfe CL. Heat shock protein induction in rats. A role for improved myocardial salvage after ischemia reperfusion. Circulation 1992;85:769-778.
30. Yellon DM, Pasini E, Cargnoni A, Marber MS, Latchman DS, Ferrari R. The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. J Mol Cell Cardiol 1992;24:895-907.
31. +(IKR) blocker dofetilide. FASEB J 1996; 10:A319-1841.
32. Yao Z, Gross GJ. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs. Am J Physiol 1994;267:H1888-H1894.
33. Kemp BE, Parker MW, Hu S, Tiganis T, House C. Substrate and pseudosubstrate interactions with protein kinases: determinants of specificity. Trends Biochem Sci 1994;19:440-444.
34. Zeisel SH. Choline phospholipids: signal transduction and carcinogenesis. FASEB J 1993;7:551-557.
35. Rozengurt E, Sinnet-Smith J, Van Sint J, Valverde AM. Protein kinase D (PKD): A novel target for diacylglycerol and phorbol esters. Mutation Res 1995;333:153-160.
36. Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase. C. Science 1992; 258:607-614.
37. Pucéat M, Brown JH. Protein kinase C in the heart. In: Ed. Protein kinase C, Kuo JF. London: Oxford University Press 1994;249-268.
38. Mochly-Rosen D, Khaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci 1991;88:3997-4000.
39. Ron D, Mochly-Rosen D. An autoregulatory region in protein kinase C: the pseudoanchoring site. Proc Natl Acad Sci 1995;92:492-496.
40. Pears C, Stabel S, Cauzabon S, Parker P. Studies on the phosphorylation of protein kinase C-α. Biochem J 1992;283: 515-518.
41. Hug H, Sarre TF. Protein kinase C isozymes: divergence in signal transduction. Biochem J 1993;291:329-343.
42. Kikkawa U, Go M, Koumoto J, Nishizuka Y. Rapid purification of protein kinase C by high performance liquid chromatography. Biochem Biophys Res Commun 1986;135: 636-643.
43. Ruzycky A. Protein kinase C and cardiovascular contractility. In: Eds. Gwathmey JK, Briggs GM, Allan PD, Heart failure, basic science and clinical aspects. New York: Marcel Dekker, Inc. 1993;285-305.
44. Weinbrenner CE, Simonis G, Marquetant R, Strasser RH. Selective regulation of calcium-dependent and calcium-independent subtypes of protein kinase C in acute and prolonged myocardial ischemia (Abstract). Circulation 1993; 88(Suppl 1):I-101.
45. Lamers JMJ, Eskildsen-Helmond YEG, Resink AM, De Jonge HW, Bezstarosti K, Sharma HS, Van Heugten HAA. Endothelin-1-induced phospholipase C-β and D and protein kinase C isoenzyme signalling leading to hypertrophy in rat cardiomyocytes. J Cardiovasc Pharmacol 1995;26(suppl. 3): S100-S103.
46. Bogoyevitch MA, Parker PJ, Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Circ Res 1993;72:757-767.
47. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing heart. Circ Res 1994; 74:299-309.
48. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
49. Taguchi K, Erdbrügger W, Phillip T, Michel CM. Identification of protein kinase C (PKC) isoforms in the rat cardiovascular tissues (Abstract). FASEB J 1996;10:A683.
50. Gerardo JA, Lust RM. Expression of PKC isoforms in adult canine cardiac myocytes (Abstract). FASEB J 1996;10: A314.
51. Eskildsen-Helmond YEG, Gho BCG, Bezstarosti K, Dekkers DHW, Soei LK, Van Heugten HAA, Verdouw PD, Lamers JMJ. Exploration of the possible roles of phospholipase D and protein kinase C in the mechanism of preconditioning in the myocardium. Ann N Y Acad Sci, 1996;793: 210-225.
52. Ytrehus K, Liu Y, Downey JM. Preconditioning protect the ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
53. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
54. Kloner RA, Przyklenk K, Whittaker P, Hale S. Preconditioning stimuli and inadvertent preconditioning. J Mol Cell Cardiol 1995;27:743-747.
55. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-585.
56. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883-892.
57. Guillemain I, Rossignol B. Protein kinase C and phospholipase D activation in rat parotid glands. FEBS Letters 1995; 363:13-16.
58. Eskildsen-Helmond YEG, Van Heugten HAA, Lamers JMJ. Regulation and functional significance of phospholipase D in myocardium. Mol Cell Biochem 1996;157: 39-48.
59. Exton JH. Phosphatidylcholine breakdown and signal transduction. Biochem Biophys Acta 1994;1212:26-42.
60. Nakamura S, Nishizuka Y. Lipid mediators and PKC activation for the intracellular signalling network. J Biochem 1994;115:1029-1034.
61. Johnson JA, Adak S, Mochly-Rosen D. Prolonged phorbol ester treatment down-regulates protein kinase C isozymes and increases contraction rate in neonatal cardiac myocytes. Life Sciences 1995;57:1027-1038.
62. Cohen MV, Yang XM, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 1994;74:998-1004.
63. Liu Y, Ytrehus K, Downey LM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994; 26:661-668.
64. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model. Circulation 1995;92: 1546-1557.
65. + channel. Studies of the contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995;77:1030-1035.
66. Bugge E, Ytrehus K. Ischemic preconditioning is protein kinase C dependent but not through stimulation of α-adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995;29:401-406.
67. Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 1994;8:881-882.
68. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 1995; 268:H426-H431.
69. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo (Abstract). Circulation 1994;90(suppl. I):I-647.
70. Tamaoki T. Use and the specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol 1991;201:340-347.
71. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989;159:548-553.
72. Harding AE, Jaggar JH, Squires PE, Dunne MJ. Protein kinase C and the modulation of ATP-sensitive potassium channels in insulin-secreting cells. Biochem Soc Trans 1993; 21:3888.
73. Harding EA, Jaggar JH, Squires PE, Dunne MJ. Polymyxin B has multiple blocking actions on the ATP-sensitive potassium channel in insulin-secreting cells. Pflügers Arch (Eur J Phys) 1994;426:31-39.
74. Steinberg SF, Goldberg M, Rybin VO. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 1995;27: 141-153.
75. Harrington EO, Ware JA. Diversity of the protein kinase C gene family. Implications for cardiovascular disease. Trends Cadiovasc Med 1995;5:193-198.
76. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1990;291:329-343.
77. Mochly-Rosen D, Heinrich CJ, Cheever L, Khaner H, Simpson PC. A protein kinase C isoenzyme is translocated to cytoskeletal elements on activation. Cell Regul 1990;1: 693-706.
78. Cohen MV, Liu Y, Downey JM. Activation of protein kinase C is critical to the protection of preconditioning. In: Eds. Wainwright CL and Parrat JR. Myocardial preconditioning. New York: Chapman & Hall; Texas (USA): R.G. Landes Company. 1996:185-206.
79. Schaap D, Parker PJ. Expression, purification, and characterization of protein kinase C-ε. J Biol Chem 1990;265: 7301-7307.
80. Koning MMG, Simonis LAJ, De Zeeuw S, Nieukoop S, Pots S, Verdouw PD. Ischaemic preconditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res 1994; 28:1146-1151.
81. Mochly-Rosen D, Khaner H, Lopez J, Smith BL. Intracellular receptors for activated protein kinase C, identification of a binding site for the enzyme. J Biol Chem 1991;266: 14866-14868.
82. Brooks G, Walsh R, Downey J. Phosphorylation of 80K/ MARCKS, a specific substrate of protein kinase C occurs after 5′ ischemia but only in preconditioned hearts (Abstract). Circulation 1993;88(SupplI):101.
83. Dekker LV, Parker PJ. Protein kinase C-a question of specificity. Trends Biochem Sci 1994;19:73-77.